4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-085658
General Counsel sold 1,391 shares at an average $0.74 ($1,035)
From the SEC's structured data for this filing
Trades in this filing
Miller Edward · General Counsel
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-07-19 | Sale : show line 1 in the form | −634 | $0.75 | $476 | 219,483 | D |
| 2024-07-22 | Sale : show line 2 in the form | −757 | $0.74 | $560 | 218,726 | D |
| Open-market sales · 1,391 sh · avg $0.74 · $1,035 | ||||||
Loading xslF345X05/ownership.xml…